Last reviewed · How we verify
Taking drug Tamsulosin
At a glance
| Generic name | Taking drug Tamsulosin |
|---|---|
| Sponsor | Joint-Stock Company North-West Center for Evidence-Based Medicine, Russian Federation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery (PHASE3)
- Exploration of Pupil Dilation in Horner's Patients Taking Flomax (PHASE4)
- The Effectiveness of Peripheral Magnetic Stimulation in Men With Lower Urinary Tract Symptoms (NA)
- Corneal Endothelium Cell Loss After Cataract Extraction in Patients Taking Tamsulosin
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: